Kalkine has a fully transformed New Avatar.

Cleanspace Holdings Ltd

Healthcare AU CSX

0.5AUD
-0.025(4.76%)

Last update at 2026-03-11T00:10:00Z

Day Range

0.500.51
LowHigh

52 Week Range

0.370.88
LowHigh

Fundamentals

  • Previous Close 0.53
  • Market Cap41.09M
  • Volume24598
  • P/E Ratio25.00
  • Dividend Yield-%
  • EBITDA-1.07112M
  • Revenue TTM20.66M
  • Revenue Per Share TTM0.26
  • Gross Profit TTM 15.48M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.03308M -4.58955M -11.82657M -15.27697M 15.96M
Minority interest - - - - -
Net income -0.47828M -3.12714M -8.13159M -11.28144M 11.39M
Selling general administrative 3.59M 12.05M 18.45M 17.14M 16.02M
Selling and marketing expenses 1.02M 1.56M - 4.05M 3.68M
Gross profit 14.78M 11.36M 8.41M 9.75M 40.27M
Reconciled depreciation 0.92M 0.96M 1.04M 1.02M 1.13M
Ebit -1.28095M -4.44883M -11.83134M -15.13143M 16.01M
Ebitda -0.82455M -3.49180M -10.62730M -14.11498M 17.15M
Depreciation and amortization 0.46M 0.96M - 1.02M 1.13M
Non operating income net other - - - - -
Operating income -1.28095M -4.74341M -11.81980M -15.13143M 16.01M
Other operating expenses 21.05M 20.54M - 28.48M 34.01M
Interest expense 0.09M 0.14M 0.16M 0.16M 0.00822M
Tax provision -0.55480M -1.46241M -3.69498M -3.99553M 4.57M
Interest income 0.34M 0.37M 0.00677M 0.06M 0.07M
Net interest income 0.25M 0.22M -0.00677M -0.20684M -0.06874M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.55M -1.46241M -3.69498M -3.99553M 4.57M
Total revenue 19.76M 15.72M 12.09M 13.36M 49.93M
Total operating expenses 16.06M 16.17M - 24.87M 24.35M
Cost of revenue 4.99M 4.36M 3.69M 3.61M 9.66M
Total other income expense net 0.25M 0.15M 0.00905M 0.05M 0.11M
Discontinued operations - - - - -
Net income from continuing ops -0.47828M -3.12714M -8.13159M -11.28144M 11.39M
Net income applicable to common shares -0.47828M -3.12714M -8.13159M -11.28144M 11.39M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 27.57M 26.05M 28.98M 38.36M 50.72M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.41M 1.24M 3.48M 0.48M
Total liab 8.41M 6.95M 7.02M 8.60M 9.99M
Total stockholder equity 19.16M 19.10M 21.96M 29.75M 40.73M
Deferred long term liab - - - - -
Other current liab - 2.57M 1.55M 3.41M 4.34M
Common stock - 33.55M 33.44M 33.43M 33.43M
Capital stock 33.87M - 33.44M 33.43M 33.43M
Retained earnings -15.49403M -15.17476M -12.23304M -4.15700M 6.76M
Other liab - - 0.36M 0.42M 0.47M
Good will - - - - -
Other assets - 0.00000M 6.31M 0.90M 1.06M
Cash 2.52M 2.75M 3.12M 8.22M 22.21M
Cash and equivalents - - - - -
Total current liabilities 3.62M 3.76M 3.30M 7.02M 7.92M
Current deferred revenue - 0.04M - - 4.33M
Net debt 0.31M 0.70M - -4.09396M -17.82448M
Short term debt - 0.53M 0.00000M 2.97M 2.78M
Short long term debt - - 0.15M 2.53M 2.37M
Short long term debt total - 3.45M - 4.13M 4.38M
Other stockholder equity - - 0.75M 0.48M 0.53M
Property plant equipment - - 2.40M 3.44M 3.85M
Total current assets 18.38M 17.64M 20.26M 33.99M 45.77M
Long term investments - - - - -
Net tangible assets - - 21.95M 29.73M 40.69M
Short term investments 7.95M 7.02M 9.04M 16.08M 16.03M
Net receivables 3.52M 4.59M 3.32M 2.47M 2.44M
Long term debt 2.83M - 2.68M - 0.00293M
Inventory 2.25M 2.87M 2.99M 3.74M 4.61M
Accounts payable 0.71M 0.62M 0.26M 0.64M 0.80M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.73M - 0.48M 0.53M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M - - -
Deferred long term asset charges - - - - -
Non current assets total 9.19M 8.41M 8.72M 4.36M 4.95M
Capital lease obligations 1.70M - 1.16M 1.60M 2.01M
Long term debt total - - 3.36M 1.16M 1.60M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.77838M 2.00M 7.04M -0.04374M -12.45809M
Change to liabilities - - -4.02448M 0.48M -2.75069M
Total cashflows from investing activities -0.77838M 2.00M 7.06M -0.62800M -14.18492M
Net borrowings - -0.15404M -0.21149M -0.35795M -2.89190M
Total cash from financing activities -0.55987M -0.63709M -0.21149M -0.35795M 16.19M
Change to operating activities - - 0.07M -0.11553M 0.35M
Net income -0.47828M -3.12714M -8.13159M -11.28144M 11.39M
Change in cash -0.22756M -0.36810M -5.10887M -13.98243M 15.46M
Begin period cash flow 2.75M 3.12M 8.22M 22.21M 6.74M
End period cash flow 2.52M 2.75M 3.12M 8.22M 22.21M
Total cash from operating activities 1.11M -1.72683M -11.96072M -12.99648M 13.46M
Issuance of capital stock - - - - 19.08M
Depreciation 0.92M 0.96M 1.02M 1.00M 1.11M
Other cashflows from investing activities 0.26M 2.03M 7.07M -0.02217M -12.45809M
Dividends paid - - - - -
Change to inventory 0.61M 0.12M 0.75M 0.72M -3.49503M
Change to account receivables -0.68624M -0.02385M -0.95223M -0.01281M 6.21M
Sale purchase of stock - - - 0.00000M 19.08M
Other cashflows from financing activities -0.02599M -0.48305M - -0.62800M -0.55492M
Change to netincome - - 0.41M 0.54M 1.27M
Capital expenditures 0.10M 0.03M 0.00526M 0.61M 1.73M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.04537M 0.17M 0.08M -0.10080M -5.36747M
Stock based compensation 0.41M 0.27M - - -
Other non cash items 0.30M 0.00400M - - -
Free cash flow 1.01M -1.75691M -11.96598M -0.60583M -1.72683M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CSX
Cleanspace Holdings Ltd
-0.025 4.76% 0.50 25.00 - 1.99 1.93 1.59 12.97
COH
Cochlear Ltd
-1.4 0.77% 181.12 35.04 28.33 5.17 6.50 5.41 22.39
4DX
4DMEDICAL Ltd
0.01 0.34% 4.45 - - 421.18 37.59 411.50 -7.2899
AVR
Anteris Technologies Global Corp
0.28 3.26% 8.87 - - 495.24 162.25 283.45 -5.1986
PNV
Polynovo Ltd
0.03 3.00% 0.93 92.50 30.40 4.58 7.52 4.45 89.43

Reports Covered

Stock Research & News

Profile

CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.

Cleanspace Holdings Ltd

39 Herbert Street, St Leonards, NSW, Australia, 2065

Key Executives

Name Title Year Born
Dr. Alexandra Birrell CEO & Exec. Director NA
Ms. Elizabeth Harvey CFO & Joint Company Sec. NA
Mr. Dan Kao Director of Operations & Exec. Director NA
Mr. Alex Virr Chief Technology Officer NA
Mr. Jon Imms Global Sales Director NA
Ms. Elissa Hansen Joint Company Sec. NA
Mr. Graham A. McLean CPA, CIMA CEO & Director 1965
Mr. Dan Kao Director of Innovation & Operations and Executive Director NA
Ms. Bree Greeff Interim Chief Financial Officer NA
Mr. Graham A. McLean CPA, CIMA CEO & Director 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.